On this page
What is Bronchiolitis?
Bronchiolitis is an infection affecting the small airway passages within the lungs, known as bronchioles, and is usually caused by a viral infection. Because these tiny airways are already naturally narrow in infants, even a relatively mild degree of inflammation and mucus buildup can significantly obstruct airflow, which explains why this condition can become surprisingly serious in very young children.
Bronchiolitis is a seasonal illness, particularly common during the autumn and winter months, and represents one of the most frequent causes of hospitalization among infants and children under two years of age worldwide.
The initial symptoms of bronchiolitis closely resemble those of a common cold, including a runny nose and cough. However, over the following days, the young patient typically develops:
- Fever
- A dry, persistent cough
- Feeding difficulties
- Rapid, wheezy breathing
There are no specific antiviral medications available to treat bronchiolitis directly. Fortunately, the infection generally resolves on its own within about two weeks without requiring specific medical treatment, aside from supportive care aimed at relieving symptoms and ensuring the child remains adequately hydrated and oxygenated.
Causes
Bronchiolitis predominantly affects children under two years of age, and frequently requires hospitalization when contracted within the first six months of life, with the period between three and six months of age representing the time of greatest risk.
This common, and at times serious, illness is primarily caused by respiratory syncytial virus (RSV), a highly contagious virus that circulates widely during the colder months of the year.
Other viruses that can also cause bronchiolitis include:
- Adenovirus
- Influenza virus
- Viruses responsible for parainfluenza
Interestingly, while RSV infection in adults typically causes only mild, cold-like symptoms, the same virus can lead to much more severe respiratory problems in infants and young children, whose airways are smaller and immune systems less experienced in fighting off respiratory pathogens.
The main risk factors for developing bronchiolitis during childhood include:
- Exposure to cigarette smoke
- Age under six months
- Living in crowded conditions
- Never having been breastfed
- A family history of asthma
- Being born prematurely (before 37 weeks of gestation)
How Bronchiolitis Spreads
The viruses responsible for bronchiolitis are highly contagious, and infection spreads through two main routes:
Airborne transmission, through saliva and nasal secretions that infected individuals release into the environment through sneezing, coughing, or even simply talking, laughing, or crying.
Indirect transmission, through contaminated hands or shared objects that are subsequently brought to the mouth after exposure to the virus. Notably, these viruses can survive on surfaces for an average of 24 hours, making indirect transmission a significant concern, particularly in households and childcare settings.
Respiratory droplets released by an infected patient can directly or indirectly reach the hands of others, remaining capable of spreading the infection for several hours afterward. Touching the eyes, nose, or mouth after contact with contaminated surfaces or hands can easily result in transmission of the virus.
A child with bronchiolitis should be kept away from other children and from individuals particularly vulnerable to severe respiratory infections, such as those with chronic heart or lung disease and those with weakened immune systems, until labored breathing and fever have fully resolved.
Importantly, infected children can remain capable of transmitting bronchiolitis for up to three weeks following the initial infection, even after their own symptoms have begun to improve, which has important implications for managing exposure to other vulnerable individuals.
Symptoms
The incubation period for bronchiolitis typically lasts between six and ten days, and the illness usually begins with common cold-like symptoms that then undergo significant worsening over the following three to five days.
Typical symptoms of bronchiolitis include:
- Bluish discoloration of the skin due to insufficient oxygen levels (cyanosis)
- Cough, labored breathing, shortness of breath, or difficulty breathing
- Fever
- Rapid breathing (tachypnea)
- Visible retractions between the ribs while breathing
- Wheezing
Some children experience an infection characterized by only a few mild initial symptoms, primarily runny nose and other symptoms typical of common winter illnesses, which then tends to resolve on its own without significant progression.
In more severe cases, bronchiolitis begins with a mild upper respiratory infection that, within two to three days, can develop into progressively worsening breathing difficulty, causing labored breathing and a distinctive, forceful, gasping cough.
The breathing rate can increase substantially (tachypnea), and the child may become irritable or appear visibly anxious. If the illness becomes severe enough, the face may take on a bluish tint (cyanosis), which requires immediate medical attention without delay.
Increased breathing effort often becomes visually apparent through flaring of the nostrils and visible retractions of the skin between and below the ribs, both of which are signs that the child is working significantly harder than normal to breathe. This increased effort can be profoundly exhausting for a young child, and infants in particular can become so fatigued from the constant effort of breathing that they begin to have difficulty maintaining adequate respiration altogether, a warning sign that requires urgent medical evaluation.
Bronchiolitis can occasionally occur alongside other related conditions, including middle ear infection (otitis media), conjunctivitis, and pharyngitis.
How Long Does It Last?
In most cases, symptoms begin to improve within about a week, with breathing difficulties typically starting to ease from around the third day of illness onward. However, the cough itself can persist for considerably longer, sometimes for several additional weeks even after other symptoms have fully resolved.
Dangers and Complications
The overall mortality rate associated with bronchiolitis is very low, less than 1% in developed countries with access to appropriate medical care. However, several potential complications are worth being aware of:
- Increased risk of respiratory conditions, including asthma, later in life
- Respiratory failure in severe cases
- Secondary bacterial infection, such as pneumonia
When to Call a Doctor
Call your pediatrician immediately or go to the emergency room if a child with bronchiolitis:
- Becomes lethargic (excessive drowsiness, fatigue, and reduced responsiveness to stimulation)
- Develops a bluish discoloration of the skin, nails, or lips (cyanosis)
- Develops rapid and/or weak breathing
- Suddenly feels cold to the touch
- Shows signs of significant breathing difficulty (dyspnea)
Diagnosis
The diagnosis of bronchiolitis is essentially clinical, based on a thorough medical history and physical examination performed by a pediatrician. The doctor evaluates the presence of characteristic signs, including wheezing sounds heard through a stethoscope, the use of accessory muscles to assist breathing, and the overall respiratory rate.
Assessing Severity
The primary tool used to monitor the severity of bronchiolitis is pulse oximetry, which measures blood oxygen saturation through a small sensor placed on the child’s skin, typically on a finger or toe. Oxygen saturation levels consistently below 92% (or below 90% according to some international guidelines) generally indicate the need for hospital admission for respiratory support.
Laboratory Tests and Imaging
In routine clinical practice, blood tests or chest X-rays are generally not necessary for mild to moderate cases of bronchiolitis. Laboratory testing is typically reserved for more complex cases:
Viral Testing
Testing for respiratory syncytial virus (RSV) through a nasopharyngeal swab is particularly useful in hospital settings, both to isolate infected patients and prevent the spread of infection within hospital wards, and for broader epidemiological surveillance purposes.
Chest X-ray
Chest X-rays are not routinely recommended, since they often reveal nonspecific findings that can inadvertently lead to inappropriate antibiotic use. Imaging is generally reserved for situations where complications are suspected, such as pneumothorax or superimposed bacterial pneumonia.
Blood Gas Analysis
This test is reserved for critical cases in which it becomes necessary to precisely monitor the exchange of oxygen and carbon dioxide within the blood.
Treatment
The therapeutic approach to bronchiolitis has as its primary goal supporting the child through the acute phase of the infection, ensuring adequate oxygenation and proper hydration throughout the illness. Since bronchiolitis is caused by a viral infection, management is predominantly supportive in nature, rather than curative.
Home Care and Lifestyle Management
In the majority of cases, bronchiolitis can be managed safely at home by carefully following the pediatrician’s guidance:
Nasal Hygiene
This represents the single most important intervention available. Performing frequent nasal washes with saline solution (or 3% hypertonic saline if specifically recommended by a doctor) helps clear the upper airways and makes both breathing and feeding considerably easier for the child.
Smaller, More Frequent Feedings
Children with bronchiolitis tire easily while feeding, since sucking and swallowing require considerable effort when breathing is already labored. It is advisable to offer smaller, more frequent feedings in order to prevent dehydration while reducing the respiratory effort required during breastfeeding or bottle feeding.
Positioning
Keeping the child in a semi-upright position, such as by slightly elevating the head of the mattress, can help improve overall breathing mechanics and ease respiratory effort.
A Healthy Home Environment
Smoking inside the home or in the presence of the child is absolutely prohibited, as secondhand smoke exposure can significantly worsen respiratory symptoms. The air should be kept appropriately humidified, and room temperature should not exceed approximately 20°C (68°F).
Pharmacological Treatments
Current scientific consensus takes a notably cautious stance regarding medication use in bronchiolitis, since many traditional treatments have proven to be of limited effectiveness:
Bronchodilators
The routine use of asthma medications, such as salbutamol (albuterol), is not recommended. A trial dose may occasionally be attempted under close medical supervision, but if no immediate clinical improvement is observed, treatment should be discontinued promptly.
Corticosteroids
Steroid medications, whether taken orally or by inhalation, are not recommended for the treatment of acute bronchiolitis, since studies have shown they do not reduce hospitalization rates or shorten the overall duration of symptoms.
Antibiotics
Antibiotics are not effective against viral infections and should be used exclusively when there is strong clinical suspicion of a bacterial complication, such as acute otitis media or bacterial pneumonia.
3% Hypertonic Saline
Nebulized hypertonic saline therapy may be used in hospital settings to help promote clearance of mucus from the airways, though its use in the home setting remains a subject of ongoing debate among pediatric specialists.
Hospital Support
If a child is unable to maintain adequate oxygen levels, or is unable to feed sufficiently due to respiratory distress, hospitalization becomes necessary. In the hospital setting, several supportive treatments may be provided:
Oxygen Therapy
Supplemental oxygen is provided to maintain normal saturation levels. High-flow nasal cannula (HFNC) devices, which deliver warmed and humidified oxygen, are frequently used for this purpose.
Intravenous Fluids or Nasogastric Tube Feeding
These interventions may be necessary if the child is unable to drink sufficient fluids due to the effort required for breathing.
Ventilatory Support
In the most severe cases, non-invasive mechanical ventilation, such as continuous positive airway pressure (CPAP), may be required to support breathing until the acute phase of the illness resolves.
Prevention
Significant progress has been made in the prevention of bronchiolitis in recent years. Beyond fundamental hygiene measures, such as frequent handwashing and avoiding crowded places with infants during the winter months, several new protective tools are now available:
Monoclonal Antibodies
In several countries, universal immunization has been introduced for all newborns during their first RSV season, using a long-acting monoclonal antibody called nirsevimab. This antibody provides immediate and sustained protection against severe forms of bronchiolitis, representing a major advance in prevention strategy.
Maternal Vaccination
It is now possible to vaccinate pregnant women, generally between the 24th and 36th weeks of pregnancy, allowing protective antibodies to pass to the developing fetus. This provides the newborn with a degree of natural defense against RSV during the first critical months of life.
Palivizumab
This older monoclonal antibody remains indicated for specific categories of children at extremely high risk, such as those born extremely premature or those born with severe congenital heart disease.
Paying careful attention to handwashing, particularly in environments where young children are present, contributes significantly to preventing the spread of respiratory viruses. Family members experiencing cold symptoms should wear a mask when caring for a newborn and should wash their hands thoroughly before any contact with the infant.
Frequently Asked Questions
Is bronchiolitis the same as bronchitis?
No, although the names sound similar, these are distinct conditions. Bronchiolitis affects the smallest airways (bronchioles) deep within the lungs and primarily affects infants and young children. Bronchitis affects the larger airways (bronchi) and can occur at any age, though it is more commonly discussed in the context of adults, particularly smokers.
Can adults get bronchiolitis?
While RSV, the most common cause of bronchiolitis, can infect people of any age, adults typically experience only mild, cold-like symptoms rather than true bronchiolitis. The small, narrow airways of infants make them uniquely susceptible to the more severe airway obstruction characteristic of this condition.
Is there a vaccine for bronchiolitis?
While there is no traditional vaccine given directly to infants for bronchiolitis prevention, highly effective tools now exist, including the monoclonal antibody nirsevimab, given directly to infants, and maternal RSV vaccination during pregnancy, which passes protective antibodies to the baby before birth.
Can bronchiolitis come back after recovery?
Children generally develop some immunity to the specific virus that caused their infection, but since multiple different viruses can cause bronchiolitis, it is possible, though less common, to experience the condition more than once, particularly during the same RSV season if exposed to a different virus strain.
